EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function

Silvia Belluti iD, Carol Imbriano iD, Livio Casarini iD

Cancers · 2023-09-20 · 15 (18) · 4653

DOI: 10.3390/cancers15184653 ↗

At a glance

Übersichtsarbeit in Cancers, published online on 2023-09-20. Written by Silvia Belluti and 2 co-authors. Institution: Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy. Cited 29 times so far (Crossref); 249 references. The full text is freely available (open access, CC BY 4.0). Funded by: Italian Association for Cancer Research, AIRC (Fondazione Italiana per la Ricerca sul Cancro).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Estrogens are almost ubiquitous steroid hormones that are essential for development, metabolism, and reproduction. They exert both genomic and non-genomic action through two nuclear receptors (ERα and ERβ), which are transcription factors with disregulated functions and/or expression in pathological processes. In the 1990s, the discovery of an additional membrane estrogen G-protein-coupled receptor augmented the complexity of this picture. Increasing evidence elucidating the specific molecular mechanisms of action and opposing effects of ERα and Erβ was reported in the context of prostate cancer treatment, where these issues are increasingly investigated. Although new approaches improved the efficacy of clinical therapies thanks to the development of new molecules targeting specifically estrogen receptors and used in combination with immunotherapy, more efforts are needed to overcome the main drawbacks, and resistance events will be a challenge in the coming years. This review summarizes the state-of-the-art on ERα and ERβ mechanisms of action in prostate cancer and promising future therapies.

Subjects

Author keywords

alternative splicingcancer transcript variantsestrogen receptorsestrogen-receptor-targeting drugsestrogensgene regulationprostate cancer

Authors and institutions

  • Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
  • Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Ospedale di Baggiovara, 41126 Modena, Italy.

ORCID profiles: Silvia Belluti, Carol Imbriano, Livio Casarini

Funding

  • Italian Association for Cancer Research
  • AIRC (Fondazione Italiana per la Ricerca sul Cancro)

Cite

APA

Belluti, S., Imbriano, C., & Casarini, L. (2023). Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function. Cancers, 15(18), 4653. https://doi.org/10.3390/cancers15184653

Vancouver

Belluti S, Imbriano C, Casarini L. Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function. Cancers. 2023;15(18):4653. doi:10.3390/cancers15184653

BibTeX
@article{Belluti2023,
  author = {Belluti, Silvia and Imbriano, Carol and Casarini, Livio},
  title = {Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {18},
  pages = {4653},
  doi = {10.3390/cancers15184653}
}
Start for free →